Novel approaches and therapeutics in acute‐on‐chronic liver failure
Rajiv Jalan – 2 September 2016
Strategies for minimizing immunosuppression: State of the Art
Alberto Sanchez‐Fueyo – 2 September 2016
The evolving role of the microbiome in liver failure and liver transplantation
Kymberly D. Watt – 2 September 2016
“In 10 years” debate: Con—machine perfusion will be limited to specific situations (Steatotic, donation after circulatory death)
Juan Echeverri, Markus Selzner – 2 September 2016
Surgical advances in obese candidates and recipients
Julie Heimbach – 30 August 2016
HBV therapeutic vaccines and cccDNA inhibitors – emergence of a cure
James Fung – 30 August 2016
Expanding living donor liver transplantation
Chung‐Mau Lo – 30 August 2016
Serum markers for hepatocellular carcinoma
Paul Clark – 29 August 2016
Type 2 diabetes–associated hepatocellular carcinoma: A molecular profile
Manon Allaire, Jean Charles Nault – 29 August 2016
Surveillance for cholangiocarcinoma in patients with primary sclerosing cholangitis: Effective and justified?
Nataliya Razumilava, Gregory J. Gores – 29 August 2016